Anuh Pharma Ltd. — Regulatory Filings 2023

==> picture [264 x 160] intentionally omitted <==

19[th] October, 2023

To, The Manager (Listing) BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400 001

· Ref: Scrip Code N0. 506260

Sub: Intimation of approval received for Reclassification application made under Regulation 31A of SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015

This is to inform you that regarding application to BSE Limited (“Stock Exchange”) for reclassification of certain persons from 'Promoter/Promoter Group' to 'Public Category' in accordance with Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”).

In this regard, pursuant to Regulation 30 and 31A of SEBI Listing Regulations, we would like to inform you that the Company has received approval from the Stock Exchanges for reclassification of the following persons from 'Promoter/Promoter Group' to 'Public Category'

You are requested to kindly take the same on record. Thanking You, Yours Faithfully,

For Anuh Pharma Limited

HEMANT Digitally signed by HEMANT KISAN AUTI KISAN AUTI Date: 2023.10.19 17:56:55 +05'30'

Hemant Auti Company Secretary & Compliance Officer

==> picture [451 x 63] intentionally omitted <==